This is a demo store. No orders will be fulfilled.

CF53

    级别和纯度:
  • 10mM in DMSO
  • CAS编号: 1808160-52-2
  • 分子式: C24H25N7O2
  • 分子量: 443.50
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
C654650-1ml
1ml 期货 Stock Image

基本描述

规格或纯度 10mM in DMSO
英文名称 CF53
生化机理 CF53 是一种高效、选择性和口服活性的 BET 蛋白抑制剂,其 K i 小于 1 nM,K d 为 2.2 nM,对 BRD4 BD1 的 IC 50 为 2 nM。CF53 可与 BRD2、BRD3、BRD4 和 BRDT BET 蛋白的 BD1 和 BD2 结构域结合,具有很高的亲和力。
储存温度 充氩,-80℃储存
运输条件 超低温冰袋运输
作用类型 抑制剂
产品介绍


CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a K i of <1 nM, K d of 2.2 nM and an IC 50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2 , BRD3 , BRD4 , and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo

In Vitro

CF53 (Compound 28) binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, K d s are 1.1 nM (BRD2 BD1), 0.6 nM (BRD2 BD2), 0.52 nM (BRD3 BD1), 0.49 nM (BRD3 BD2), 0.8 nM (BRD4 BD2), 2 nM (BRDT BD1), 2.1 nM (BRDT BD2), 47 nM (CREBBP), 570 nM (CECR2), 110 nM (EP300), respectively. CF53 exhibits IC 50 s of 7, 85 nM against MOLM-13 acute leukemia and MDA-MB-231 breast cancer cell lines, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

CF53 (25, 50 mg/kg, p.o.) exhibits potent anti-tumor activity both in MDA-MB-231 xenograft tumor model and in RS4;11 model in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:BRD4 (BD1) <1 nM (Ki) BRD4 (BD1) 2 nM (IC 50 ) BRD4 (BD1) 2.2 nM (Kd) BRD4 (BD2) 0.8 nM (Kd) BRD2 (BD2) 0.6 nM (Kd) BRD2 (BD1) 1.1 nM (Kd) BRD3 (BD2) 0.49 nM (Kd) BRD3 (BD1) 0.52 nM (Kd) BRDT (BD2) 1 nM (Kd) BRDT (BD1) 2 nM (Kd) CECR2 570 nM (Kd)

关联靶点(人)

EP300 Tchem 组蛋白乙酰转移酶 p300(Histone acetyltransferase p300) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
CREBBP Tchem CREB结合蛋白(CREB-binding protein) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
BRD4 Tchem 含溴结构域蛋白 4(Bromodomain-containing protein 4) (3 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
CECR2 Tchem 猫眼综合征关键区域蛋白 2(Cat eye syndrome critical region protein 2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
BRDT Tchem 溴结构域睾丸特异性蛋白(Bromodomain testis-specific protein) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
BRD3 Tchem 含溴结构域蛋白 3(Bromodomain-containing protein 3) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
BRD2 Tchem 含溴结构域蛋白 2(Bromodomain-containing protein 2) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

分子类型 小分子
Isomeric SMILES CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)NC4=C3C(=NC(=N4)C)NC5=CC(=NN5C)C6CC6)OC
PubChem CID 118340554
MeSH Entry Terms BET inhibitor CF53;N-(3-Cyclopropyl-1-methyl-1H-pyrazol-5-yl)-7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-2-methyl-9H-pyrimido(4,5-b)indol-4-amine
分子量 443.50

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器